Glycolysis inhibition for anticancer treatment

Oncogene

Volumn 25, Issue 34, 2006, Pages 4633-4646

  Pelicano, H ^a   Martin, D S ^b   Xu, R H ^c   Huang, P ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

ATP; Glycolysis; Glycolytic inhibitor; Mitochondria; Warburg effect

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; 6 AMINONICOTINAMIDE; ADENOSINE TRIPHOSPHATE; ALPHA CHLOROHYDRIN; ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; BROMINE DERIVATIVE; BROMOPYRUVIC ACID; CARMUSTINE; CISPLATIN; CYTARABINE; DEOXYGLUCOSE; DOXORUBICIN; FARNESYLTHIOSALICYLIC ACID; GENISTEIN; GLYCOLYTIC ENZYME; IMATINIB; LONIDAMINE; MANNOHEPTULOSE; MELPHALAN; ORNIDAZOLE; OXALIC ACID; OXAMIC ACID; OXYTHIAMINE; PACLITAXEL; PROTEIN INHIBITOR; PYRUVIC ACID DERIVATIVE; TH 070; THIOGLUCOSE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINCRISTINE;

AEROBIC METABOLISM; ANTINEOPLASTIC ACTIVITY; CANCER CELL; CANCER CHEMOTHERAPY; CARCINOGENESIS; CELL STRAIN MCF 7; CLINICAL TRIAL; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOSE RESPONSE; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; ENERGY YIELD; GLYCOLYSIS; HUMAN; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; INBORN ERROR OF METABOLISM; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; METABOLIC INHIBITION; METASTASIS INHIBITION; MICROENVIRONMENT; MITOCHONDRIAL RESPIRATION; NEUROTOXICITY; NONHUMAN; ONCOGENE; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SOLID TUMOR; TREATMENT RESPONSE; TUMOR CELL; WARBURG EFFECT;

ANTINEOPLASTIC AGENTS; GLYCOLYSIS; HUMANS; NEOPLASMS;

EID: 33746879141     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209597     Document Type: Review

References (151)

1. Arora KK, Fanciulli M, Pedersen PL. (1990). J Biol Chem 265:6481-6488.
2. Astuti D, Douglas F, Lennard TW, Aligianis IA, Woodward ER, Evans DG et al. (2001). Lancet 357:1181-1182.
3. Baumann M, Brand K. (1988). Cancer Res 48:7018-7021.
4. Baumann M, Kappl A, Lang T, Brand K, Siegfried W, Paterok E. (1990). Cancer Investig 8:351-356.
5. Bayley JP, Devilee P, Taschner PE. (2005). BMC Med Genet 6:39-44.
6. Beutler E, West C, Britton HA, Harris J, Forman L. (1997). Blood Cells Mol Dis 23:402-409.
7. Biaglow JE, Cerniglia G, Tuttle S, Bakanauskas V, Stevens C, McKenna G. (1997). Biochem Biophys Res Commun 235:739-742.
8. Blum R, Jacob-Hirsch J, Amariglio N, Rechavi G, Kloog Y. (2005). Cancer Res 65:999-1006.
9. Board M, Colquhoun A, Newsholme E, High A. (1995). Cancer Res 55:3278-3285.
10. Bolin DC, Carlton WW. (1996). Vet Hum Toxicol 38:85-88.
11. Boren J, Cascante M, Marin S, Comín-Anduix B, Centelles JJ, Lim S et al. (2001). J Biol Chem 276:37747-37753.
12. Bork P, Sander C, Valencia A. (1993). Prot Sci 2:31-40.
13. Boros LG, Bassilian S, Lim S, Lee WN. (2001). Pancreas 22:1-7.
14. Brahimi-Horn MC, Pouyssegur J. (2005). Int Rev Cytol 242:157-213.
15. Briasoulis E, Pavlidis N, Terret C, Bauer J, Fiedler W, Schoffski P et al. (2003). Eur J Cancer 39:2334-2340.
16. Brown J. (1962). Metabolism 11:1098-1112.
17. Bryson JM, Coy PE, Gottlob K, Hay N, Robey RB. (2002). J Biol Chem 277:11392-11400.
18. Budihardjo II, Walker DL, Svingen PA, Buckwalter CA, Desnoyers S, Eckdahl S et al. (1998). Clin Cancer Res 4:117-130.
19. Burgering BM, Coffer PJ. (1995). Nature 376:599-602.
20. Bustamante E, Pedersen PL. (1977). Proc Natl Acad Sci USA 74:3735-3739.
21. Cárdenas ML, Cornish-Bowden A, Ureta T. (1998). Biochim Biophys Acta 1401:242-264.
22. Carew JS, Huang P. (2002). Mol Cancer 1:9-20.
23. Carew JS, Zhou Y, Albitar M, Carew JD, Keating MJ, Huang P. (2003). Leukemia 17:1437-1447.
24. Cattaneo A, Biocca S, Corvaja N, Calissano P. (1985). Exp Cell Res 161:130-140.
25. Chen JZ, Kadlubar FF. (2004). J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 22:1-12.
26. Chuang DM, Hough C, Senatorov VV. (2005). Annu Rev Pharmacol Toxicol 45:269-290.
27. Comin-Anduix B, Boren J, Martinez S, Moro C, Centelles JJ, Trebukhina R et al. (2001). Eur J Biochem 268:4177-4182.
28. Coy JF, Dressler D, Wilde J, Schubert P. (2005). Clin Lab 51:257-273.
29. Danial NN, Gramm CF, Scorrano L, Zhang CY, Krauss S, Ranger AM et al. (2003). Nature 424:952-956.
30. Dastoor Z, Dreyer JL. (2001). J Cell Sci 114:1643-1653.
31. De Lena M, Lorusso V, Latorre A, Fanizza G, Gargano G, Caporusso L et al. (2001). Eur J Cancer 37:364-368.
32. Deprez J, Vertommen D, Alessi DR, Hue L, Rider MH. (1997). J Biol Chem 272:17269-17275.
33. Di Cosimo S, Ferretti G, Papaldo P, Carlini P, Fabi A, Cognetti F. (2003). Drugs Today (Barc) 39:157-174.
34. Dollner R, Dietz A, Kopun M, Helbig M, Wallner F, Granzow C. (2004). Anticancer Res 24:2947-2951.
35. Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR, et al. (2004). Cancer Res 64:3892-3899.
36. El-Zarruk AA, van den Berg HW. (1999). Cancer Lett 142:185-193.
37. Feo S, Arcuri D, Piddini E, Passantino R, Giallongo A. (2000). FEBS Lett 473:47-52.
38. Filella X, Molina R, Jo J, Mas E, Ballesta AM. (1991). Tumour Biol 12:360-367.
39. Flier JS, Mueckler MM, Usher P, Lodish HF. (1987). Science 235:1492-1495.
40. Floridi A, Bruno T, Miccadei S, Fanciulli M, Federico A, Paggi MG. (1998). Biochem Pharmacol 56:841-849.
41. Floridi A, Paggi MG, Marcante ML, Silvestrini B, Caputo A, De Martino C. (1981). J Natl Cancer Inst 66:497-499.
42. Ford WC. (2006). Hum Reprod Update 12:269-274.
43. Funasaka T, Haga A, Raz A, Nagase H. (2001). Biochem Biophys Res Commun 285:118-128.
44. Funasaka T, Haga A, Raz A, Nagase H. (2002). Int J Cancer 101:217-223.
45. Garg AK, Buchholz TA, Aggarwal BB. (2005). Antioxid Redox Signal 7:1630-1647.
46. Gatenby RA, Gillies RJ. (2004). Nat Rev Cancer 4:891-899.
47. Geschwind JF, Georgiades CS, Ko YH, Pedersen PL. (2004). Expert Rev Anticancer Ther 4:449-457.
48. Geschwind JF, Ko YH, Torbenson MS, Magee C, Pedersen PL. (2002). Cancer Res 62:3909-3913.
49. Giaccone G, Smit EF, de Jonge M, Dansin E, Briasoulis E, Ardizzoni A et al. (2004). Eur J Cancer 40:667-672.
50. Golshani-Hebroni SG, Bessman SP. (1997). J Bioenerg Biomembr 29:331-338.
51. Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N. (2001). Genes Dev 15:1406-1418.
52. Gottschalk S, Anderson N, Hainz C, Eckhardt SG, Serkova NJ. (2004). Clin Cancer Res 10:6661-6668.
53. Grosse F, Nasheuer HP, Scholtissek S, Schomburg U. (1986). Eur J Biochem 160:459-467.
54. Harrison RA. (1974). Anal Biochem 61:500-507.
55. Herrero P, Galindez J, Ruiz N, Martinez-Campa C, Moreno F. (1995). Yeast 11:137-144.
56. Hirono Y, Fushida S, Yonemura Y, Yamamoto H, Watanabe H, Raz A. (1996). Br J Cancer 74:2003-2007.
57. Ishitani R, Chuang DM. (1996). Proc Natl Acad Sci USA 93:9937-9941.
58. Izyumov DS, Avetisyan AV, Pletjushkina OY, Sakharov DV, Wirtz KW, Chernyak BV et al. (2004). Biochim Biophys Acta 1658:141-147.
59. Jelks KB, Miller MG. (2001). Toxicol Sci 62:115-123.
60. Jones AR, Cooper TG. (1997). Xenobiotica 27:711-721.
61. Kang HT, Hwang ES. (2005). Life Sci 78:1392-1399.
62. Karnauskas R, Niu Q, Talapatra S, Plas DR, Greene ME, Crispino JD et al. (2003). Oncogene 22:688-698.
63. Kim SU, Wenger BS. (1973). Acta Neuropathol (Berl) 26:259-264.
64. Ko YH, Pedersen PL, Geschwind JF. (2001). Cancer Lett 173:83-91.
65. Ko YH, Smith BL, Wang Y, Pomper MG, Rini DA, Torbenson MS et al. (2004). Biochem Biophys Res Commun 324:269-275.
66. Kohn AD, Summers SA, Birnbaum MJ, Roth RA. (1996). J Biol Chem 271:31372-31378.
67. Koutcher JA, Alfieri AA, Stolfi RL, Devitt ML, Colofiore JR, Nord LD et al. (1993). Cancer Res 53:3518-3523.
68. Layzer RB, Rowland LP, Bank WJ. (1969). J Biol Chem 244:3823-3831.
69. Ledoux S, Yang R, Friedlander G, Laouari D. (2003). Cancer Res 63:7284-7290.
70. Li C, Xiao Z, Chen Z, Zhang X, Li J, Wu X et al. (2006). Proteomics 6:547-558.
71. Lian F, Bhuiyan M, Li YW, Wall N, Kraut M, Sarkar FH. (1998). Nutr Cancer 31:184-191.
72. Lieberthal W, Menza SA, Levine JS. (1998). Am J Physiol Renal Physiol 274:F315-F327.
73. Liotta LA, Mandler R, Murano G, Katz DA, Gordon RK, Chiang PK et al. (1986). Proc Natl Acad Sci USA 83:3302-3306.
74. Little E, Ramakrishnan M, Roy B, Gazit G, Lee AS. (1994). Crit Rev Eukaryotic Gene Expression 4:1-18.
75. Liu H, Hu YP, Savaraj N, Priebe W, Lampidis TJ. (2001). Biochemistry 40:5542-5547.
76. Liu H, Savaraj N, Priebe W, Lampidis TJ. (2002). Biochem Pharmacol 64:1745-1751.
77. Lynch RM, Fogarty KE, Fay FS. (1991). J Cell Biol 112:385-395.
78. Maher JC, Krishan A, Lampidis TJ. (2004). Cancer Chemother Pharmacol 53:116-122.
79. Majewski N, Nogueira V, Robey RB, Hay N. (2004). Mol Cell Biol 24:730-740.
80. Marangos PJ, Parma AM, Goodwin FK. (1978). J Neurochem 31:727-732.
81. Martin DS, Spriggs D, Koutcher JA. (2001). Apoptosis 6:125-131.
82. Martin DS, Stolfi RL, Colofiore JR, Nord LD. (1996). Anticancer Drugs 7:655-659.
83. Martin DS, Stolfi RL, Colofiore JR, Nord LD, Sternberg S. (1994). Cancer Invest 12:296-307.
84. Maschek G, Savaraj N, Priebe W, Braunschweiger P, Hamilton K, Tidmarsh GF et al. (2004). Cancer Res 64:31-34.
85. Mathupala SP, Heese C, Pedersen PL. (1997a). J Biol Chem 272:22776-22780.
86. Mathupala SP, Rempel A, Pedersen PL. (1997b). J Bioenerg Biomembr 29:339-343.
87. Mazurek S, Boschek CB, Hugo F, Eigenbrodt E. (2005). Semin Cancer Biol 15:300-308.
88. Munoz-Pinedo C, Ruiz-Ruiz C, Ruiz de Almodovar C, Palacios C, Lopez-Rivas A. (2003). J Biol Chem 278:12759-12768.
89. Nabi IR, Watanabe H, Raz A. (1990). Cancer Res 50:409-414.
90. Nagy E, Henics T, Eckert M, Miseta A, Lightowlers RN, Kellermayer M. (2000). Biochem Biophys Res Commun 275:253-260.
91. Natali PG, Salsano F, Viora M, Nista A, Malorni W, Marolla A et al. (1984). Oncology 41:7-14.
92. Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, et al., European-American Paraganglioma Study Group. (2004). J Am Med Assoc 292:943-951.
93. Niederacher D, Entian KD. (1991). Eur J Biochem 200:311-319.
94. Niinaka Y, Paku S, Haga A, Watanabe H, Raz A. (1998). Cancer Res 58:2667-2674.
95. Niizeki H, Kobayashi M, Horiuchi I, Akakura N, Chen J, Wang J et al. (2002). Br J Cancer 86:1914-1919.
96. Oudard S, Carpentier A, Banu E, Fauchon F, Celerier D, Poupon MF et al. (2003). J Neurooncol 63:81-86.
97. Papaldo P, Lopez M, Cortesi E, Cammilluzzi E, Antimi M, Terzoli E et al. (2003). J Clin Oncol 21:3462-3468.
98. Pastorino JG, Hoek JB. (2003). Curr Med Chem 10:1535-1551.
99. Pastorino JG, Shulga N, Hoek JB. (2002). J Biol Chem 277:7610-7618.
100. Pawlu C, Bausch B, Hartmut PH. (2005). Familial Cancer 4:49-54.
101. Pelicano H, Carney D, Huang P. (2004). Drug Resist Update 7:97-110.
102. Penkowa M, Quintana A, Carrasco J, Giralt M, Molinero A, Hidalgo J. (2004). J Neurosci Res 77:35-53.
103. Perucho M, Salas J, Salas ML. (1980). Biochim Biophys Acta 606:181-195.
104. Pirinen E, Heikkinen S, Malkki M, Deeb SS, Janne J, Laakso M. (2004). Biochim Biophys Acta 1676:149-154.
105. Pollard PJ, Wortham NC, Tomlinson IP. (2003). Ann Med 35:632-639.
106. Rais B, Comin B, Puigjaner J, Brandes JL, Creppy E, Saboureau D et al. (1999). FEBS Lett 456:113-118.
107. Ramanathan A, Wang C, Schreiber SL. (2005). Proc Natl Acad Sci USA 102:5992-5997.
108. Rathmell JC, Fox CJ, Plas DR, Hammerman PS, Cinalli RM, Thompson CB. (2003). Mol Cell Biol 23:7315-7328.
109. Rempel A, Mathupala SP, Griffin CA, Hawkins AL, Pedersen PL. (1996). Cancer Res 56:2468-2471.
110. Rodriguez A, De La Cera T, Herrero P, Moreno F. (2001). Biochem J 355:625-631.
111. Rosbe KW, Brann TW, Holden SA, Teicher BA, Frei III E. (1989). Cancer Chemother Pharmacol 25:32-36.
112. Ruderman NB, Kapeller R, White MF, Cantley LC. (1990). Proc Natl Acad Sci USA 87:1411-1415.
113. Seker H, Bertram B, Burkle A, Kaina B, Pohl J, Koepsell H et al. (2000). Br J Cancer 82:629-634.
114. Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD et al. (2005). Cancer Cell 7:77-85.
115. Semenza GL, Artemov D, Bedi A, Bhujwalla Z, Chiles K, Feldser D et al. (2001). Novartis Found Symp 240:251260.
116. Serkova N, Boros LG. (2005). Am J Pharmacogenomics 5:293-302.
117. Shashidharan P, Chalmers-Redman RM, Carlile GW, Rodic V, Gurvich N, Yuen T et al. (1999). NeuroReport 10:1149-1153.
118. Singh D, Banerji AK, Dwarakanath BS, Tripathi RP, Gupta JP, Mathew TL et al. (2005). Strahlenther Onkol 181:507-514.
119. Singh KK. (2004). Ann NY Acad Sci 1019:260-264.
120. Sirover MA. (2005). J Cell Biochem 95:45-52.
121. Strumilo SA, Senkevich SB, Vinogradov VV. (1984). Biomed Biochim Acta 43:159-163.
122. Sun YJ, Chou CC, Chen WS, Wu RT, Meng M, Hsiao CD. (1999). Proc Natl Acad Sci USA 96:5412-5417.
123. Taguchi K, Takagi Y. (2001). Rinsh Byori 116:117-124.
124. Tajima H, Tsuchiya K, Yamada M, Kondo K, Katsube N, Ishitani R. (1999). Neuro Report 10:2029-2033.
125. Taylor RW, Turnbull DM. (2005). Nat Rev Genet 6:389-402.
126. Tretter L, Adam-Vizi V. (2005). Philos Trans R Soc Lond B Biol Sci 360:2335-2345.
127. VandeBerg JL. (1985). Isozymes Curr Top Biol Med Res 12:133-187.
128. Van Schaftingen E, Hers HG. (1986). Eur J Biochem 159:359-365.
129. Varshney R, Adhikari JS, Dwarakanath BS. (2003). Indian J Exp Biol 41:1384-1391.
130. Varshney R, Dwarakanath B, Jain V. (2005). Int J Radiat Biol 81:397-408.
131. Veyhl M, Wagner K, Volk C, Gorboulev V, Baumgarten K, Weber WM et al. (1998). Proc Natl Acad Sci USA 95:2914-2919.
132. Vora S. (1983). Isozymes Curr Top Biol Med Res 11:3-23.
133. Waltron RT, Rozengurt E. (2000). J Biol Chem 275:17114-17121.
134. Warburg O. (1930). The Metabolism of Tumors. Costable: London.
135. Warburg O. (1956). Science 123:309-314.
136. Warburg O, Posener K, Negelein E. (1924). Biochem Z 152:309-344.
137. Watanabe H, Takehana K, Date M, Shinozaki T, Raz A. (1996). Cancer Res 56:2960-2963.
138. Weindruch R, Keenan KP, Carney JM, Fernandes G, Feuers RJ, Floyd RA et al. (2001). J Gerontol A Biol Sci Med Sci 56:20-33.
139. Williams KR, Reddigari S, Patel GL. (1985). Proc Natl Acad Sci USA 82:5260-5264.
140. Wilson JE. (1995). Rev Physiol Biochem Pharmacol 126:65-198.
141. Wilson JE. (2003). J Exp Biol 206:2049-2057.
142. Xu LZ, Weber IT, Harrison RW, Gidh-Jain M, Pilkis SJ. (1995). Biochemistry 34:6083-6092.
143. Xu RH, Pelicano H, Zhang H, Giles FJ, Keating MJ, Huang P. (2005a). Leukemia 19:2153-2158.
144. Xu RH, Pelicano H, Zhou Y, Carew JS, Feng L, Bhalla KN et al. (2005b). Cancer Res 65:613-621.
145. Yoon DY, Buchler P, Saarikoski ST, Hines OJ, Reber HA, Hankinson O. (2001). Biochem Biophys Res Commun 288:882-886.
146. Zhao YB, Yang HY, Zhang XW, Chen GY. (2005). World J Gastroenterol 11:3304-3306.
147. Zheng L, Roeder RG, Luo Y. (2003). Cell 114:255-266.
148. Zhou JR, Gugger ET, Tanaka T, Guo Y, Blackburn GL, Clinton SK. (1999). J Nutr 129:1628-1635.
149. Zhu W, Qin W, Bradley P, Wessel A, Puckett CL, Sauter ER. (2005). Carcinogenesis 26:145-152.
150. Zong WX, Ditsworth D, Bauer DE, Wang ZQ, Thompson CB. (2004). Genes Dev 18:1272-1282.
151. Zu XL, Guppy M. (2004). Biochem Biophys Res Commun 313:459-465.